604O Phase I dose escalation and initial dose expansion results of AMG 193: A MTA-cooperative PRMT5 inhibitor, in patients (pts) with MTAP-deleted solid tumors

Adrian G. Sacher, Miguel A. Villalona‐Calero, Bert H. O’Neil, J. Rodon, Toshihiko Doi, S. Postel-Vinay, F. Ghiringhelli, Naofumi Yamamoto, S. Wahlroos, Liza C. Villaruz, Aya El Helali, Y. Fujiwara, A. Addeo, C-C Lin, E. Fontana, C-H. Chuang, C. Liu, Torsten Eggert, Nicolas Penel, Hans Prenen